Furthermore, we identify a novel molecular mechanism involving the EGFR-ProT-NF-κB-HOTAIR signaling axis in bladder cancer cachexia induced by cisplatin chemotherapy. Here, SLC6A7 is linked to urinary bladder carcinoma.